Multiple Assemblies exist for SMTL entry 5v0n
BACE1 in complex with inhibitor 5g; X-RAY DIFFRACTION 2.15 Å

	SMTL ID 5v0n.1 Ligands SULFATE ION; N-{(1S,2S)-1-[(2S)-4-benzyl-3-oxopiperazin-2-yl]-1-hydroxy-3-phenylpropan-2-yl}-7-ethyl-1,3,3-trimethyl-2,2-dioxo-1,2,3,4-tetrahydro-2lambda~6~-[1,2,5]thiadiazepino[3,4,5-hi]indole-9-carboxamide; UREA Polypeptides Beta-secretase 1 Oligo-state monomer
	SMTL ID 5v0n.2 Ligands SULFATE ION; GLYCEROL; N-{(1S,2S)-1-[(2S)-4-benzyl-3-oxopiperazin-2-yl]-1-hydroxy-3-phenylpropan-2-yl}-7-ethyl-1,3,3-trimethyl-2,2-dioxo-1,2,3,4-tetrahydro-2lambda~6~-[1,2,5]thiadiazepino[3,4,5-hi]indole-9-carboxamide; UREA Polypeptides Beta-secretase 1 Oligo-state monomer
	SMTL ID 5v0n.3 Ligands SULFATE ION; N-{(1S,2S)-1-[(2S)-4-benzyl-3-oxopiperazin-2-yl]-1-hydroxy-3-phenylpropan-2-yl}-7-ethyl-1,3,3-trimethyl-2,2-dioxo-1,2,3,4-tetrahydro-2lambda~6~-[1,2,5]thiadiazepino[3,4,5-hi]indole-9-carboxamide Polypeptides Beta-secretase 1 Oligo-state monomer